These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 15736314)

  • 1. Lamotrigine-induced rash--worth a rechallenge.
    P-Codrea Tigaran S; Sidenius P; Dam M
    Acta Neurol Scand; 2005 Mar; 111(3):191-4. PubMed ID: 15736314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Reintroduction of treatment with lamotrigine in combination with valproate after an initial allergic skin reaction].
    Gélisse P; Crespel A
    Rev Neurol (Paris); 2006 Nov; 162(11):1122-4. PubMed ID: 17086149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of Lamotrigine-associated rash.
    Hirsch LJ; Weintraub DB; Buchsbaum R; Spencer HT; Straka T; Hager M; Resor SR
    Epilepsia; 2006 Feb; 47(2):318-22. PubMed ID: 16499755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An active-control trial of lamotrigine monotherapy for partial seizures.
    Gilliam F; Vazquez B; Sackellares JC; Chang GY; Messenheimer J; Nyberg J; Risner ME; Rudd GD
    Neurology; 1998 Oct; 51(4):1018-25. PubMed ID: 9781523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of lamotrigine monotherapy in children and adolescents with epilepsy.
    Valencia I; Piñol-Ripoll G; Khurana DS; Hardison HH; Kothare SV; Melvin JJ; Marks HG; Legido A
    Eur J Paediatr Neurol; 2009 Mar; 13(2):141-5. PubMed ID: 18585941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-reactivity of skin rashes with current antiepileptic drugs in Chinese population.
    Wang XQ; Lang SY; Shi XB; Tian HJ; Wang RF; Yang F
    Seizure; 2010 Nov; 19(9):562-6. PubMed ID: 20888266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effectiveness and role of lamotrigine in the paradigm shift towards new antiepileptic drugs: a therapeutic strategy proposed after an investigation of a large number of cases at a single hospital].
    Yamamoto T; Yamazoe T; Fujimoto A; Kobayashi R; Yokota T; Okanishi T; Uchiyama G; Ohashi T; Tanaka T; Enoki H
    Brain Nerve; 2014 Jan; 66(1):59-69. PubMed ID: 24371132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lamotrigine high-dose tolerability and safety in patients with epilepsy: a double-blind, placebo-controlled, eleven-week study.
    Matsuo F; Gay P; Madsen J; Tolman KG; Rollins DE; Risner ME; Lai AA
    Epilepsia; 1996 Sep; 37(9):857-62. PubMed ID: 8814098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of lamotrigine in idiopathic generalized epilepsy syndromes: a video-EEG-controlled, open study.
    Gericke CA; Picard F; de Saint-Martin A; Strumia S; Marescaux C; Hirsch E
    Epileptic Disord; 1999 Sep; 1(3):159-65. PubMed ID: 10937148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurotoxicity following addition of intravenous valproate to lamotrigine therapy.
    Burneo JG; Limdi N; Kuzniecky RI; Knowlton RC; Mendez M; Lawn N; Faught E; Welty TE; Prasad A
    Neurology; 2003 Jun; 60(12):1991-2. PubMed ID: 12821749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lamotrigine-associated rash: to rechallenge or not to rechallenge?
    Lorberg B; Youssef NA; Bhagwagar Z
    Int J Neuropsychopharmacol; 2009 Mar; 12(2):257-65. PubMed ID: 18845017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlating lamotrigine serum concentrations with tolerability in patients with epilepsy.
    Hirsch LJ; Weintraub D; Du Y; Buchsbaum R; Spencer HT; Hager M; Straka T; Bazil CW; Adams DJ; Resor SR; Morrell MJ
    Neurology; 2004 Sep; 63(6):1022-6. PubMed ID: 15452293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adding lamotrigine to valproate: incidence of rash and other adverse effects. Postmarketing Antiepileptic Drug Survey (PADS) Group.
    Faught E; Morris G; Jacobson M; French J; Harden C; Montouris G; Rosenfeld W
    Epilepsia; 1999 Aug; 40(8):1135-40. PubMed ID: 10448828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between antiepileptic drug dose and long-term response in patients with refractory epilepsy.
    Poolos NP; Castagna CE; Williams S; Miller AB; Story TJ
    Epilepsy Behav; 2017 Apr; 69():59-68. PubMed ID: 28235655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of a lamotrigine-related skin rash: current meta-analysis and postmarketing cohort analysis.
    Wang XQ; Xiong J; Xu WH; Yu SY; Huang XS; Zhang JT; Tian CL; Huang DH; Jia WQ; Lang SY
    Seizure; 2015 Feb; 25():52-61. PubMed ID: 25645637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depression in patients with newly diagnosed epilepsy predicts lamotrigine-induced rash: a short-term observational study.
    Park SP
    Epilepsy Behav; 2013 Jul; 28(1):88-90. PubMed ID: 23673289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lamotrigine-associated rash: risk/benefit considerations in adults and children.
    Guberman AH; Besag FM; Brodie MJ; Dooley JM; Duchowny MS; Pellock JM; Richens A; Stern RS; Trevathan E
    Epilepsia; 1999 Jul; 40(7):985-91. PubMed ID: 10403224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unblinded, randomized multicenter trial comparing lamotrigine and valproate combination with controlled-release carbamazepine monotherapy as initial drug regimen in untreated epilepsy.
    Lee BI; No SK; Yi SD; Lee HW; Kim OJ; Kim SH; Kim MK; Kim SE; Kim YS; Kim JM; Lee SJ; Shin DJ; Park SP; Kim YI; Heo K; Cho YW; Cho YJ; Kim YN
    Seizure; 2018 Feb; 55():17-24. PubMed ID: 29324401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse effects of carbamazepine, phenytoin, valproate and lamotrigine monotherapy in epileptic adult Chinese patients.
    Zeng K; Wang X; Xi Z; Yan Y
    Clin Neurol Neurosurg; 2010 May; 112(4):291-5. PubMed ID: 20071075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pharmacoepidemiologic study of factors influencing the outcome of treatment with lamotrigine in chronic epilepsy.
    Wong IC; Mawer GE; Sander JW; Lhatoo SD
    Epilepsia; 2001 Oct; 42(10):1354-8. PubMed ID: 11737172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.